10.8 mg Goserelin Acetate Implant Injection

Get a Price/Quote

MOQ : 100 Packs

10.8 mg Goserelin Acetate Implant Injection Specification

Indication
Prostate cancer, Breast cancer, Endometriosis, Uterine fibroids, Assisted reproduction

Dosage Form
Implant Injection

Salt Composition
Goserelin Acetate 10.8 mg

Feature
Sustained-release, LHRH analogue, once every 3 months administration

Ingredients
Goserelin Acetate, Biodegradable polymer matrix (implant base)

Application
Subcutaneous injection for hormone therapy

Physical Color/Texture
White to off-white cylindrical implant

Fermentation Smell
Odorless

Storage Instructions
Store below 25C, protect from light, do not freeze

Shelf Life
36 months

Therapeutic Category
Hormonal therapy, Oncology

Classification
Gonadotropin-Releasing Hormone (GnRH) agonist

Strength
10.8 mg per implant

Sterility
Sterile

Route of Administration
Subcutaneous

Prescription Status
Prescription only

Brand Name
Depends on manufacturer (Example: Zoladex)

Packing Type
Sterile pre-filled syringe with single-use applicator

10.8 mg Goserelin Acetate Implant Injection Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About 10.8 mg Goserelin Acetate Implant Injection

Experience the popular and top-tier 10.8 mg Goserelin Acetate Implant Injection, a best-seller in hormonal oncology therapy now available at a price cut. This valorous solution, often branded as Zoladex, is a grandiose choice for treating prostate and breast cancers, endometriosis, and more. Each sterile, pre-filled syringe houses a single-use applicator for subcutaneous administration. With a sustained-release biodegradable matrix, this prescription-only LHRH analogue ensures effective hormone therapy-just one implant every three months. Choose dependable, high-quality treatments from India's prominent suppliers and traders.

Application & Usage Areas of Goserelin Acetate Implant 10.8 mg

The 10.8 mg Goserelin Acetate Implant Injection is applied subcutaneously for valorous hormone therapy. Used singularly in oncological care, it treats prostate cancer, breast cancer, endometriosis, and uterine fibroids. Its sustained-release system ensures controlled hormone regulation, ideal for those requiring consistent therapy. The sterile pre-filled syringe ensures ease of application and accurate dosing, reinforcing its reputation as a grandiose treatment option in hospital and clinical settings for both men and women.

Export, Samples, and Packing Details: Goserelin Acetate 10.8 mg

We offer the Goserelin Acetate Implant Injection with prompt packing & dispatch from India's major FOB ports. With stock ready, these sterile implants reach main export markets including Southeast Asia, Africa, and the Middle East. Samples are available on request to facilitate evaluation and ordering. Each implant is securely packed to preserve sterility and product integrity throughout transit, ensuring you receive only the highest-quality hormonal therapy solutions for your clinical needs.

FAQ's of 10.8 mg Goserelin Acetate Implant Injection:

Q: How is the Goserelin Acetate Implant Injection administered?

A: The Goserelin Acetate Implant is administered as a subcutaneous injection, typically in the abdominal area, using a sterile pre-filled syringe fitted with a single-use applicator.

Q: What are the primary medical uses of the 10.8 mg Goserelin Acetate Implant?

A: This implant is mainly used for hormone therapy in prostate cancer, breast cancer, endometriosis, uterine fibroids, and assisted reproductive procedures.

Q: When should the Goserelin Acetate Implant be administered?

A: The standard administrative schedule involves one implant every three months, as directed by a healthcare professional based on your treatment plan.

Q: Where can I purchase or source the Goserelin Acetate Implant Injection?

A: You can procure this product through authorized suppliers and traders in India, who serve both domestic and global markets.

Q: What are the storage requirements for the Goserelin Acetate Implant?

A: Store the implant below 25C, protect it from light, do not freeze, and ensure the packaging remains intact to maintain sterility and effectiveness.

Q: What benefits does the sustained-release feature offer?

A: The sustained-release design delivers consistent hormone regulation over three months, reducing injection frequency and supporting more stable therapeutic outcomes.

Tell us about your requirement